Effexor XR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pam Rajendran Taub, MD

• Assistant Professor of Medicine
• University of California - San Diego
• Division of Cardiology
• San Diego, California

In patients with hilar cholangiocarcinoma and complete obstruction of both right and left hepatic ducts anxiety symptoms grief discount effexor xr online american express, extrahepatic bile ducts and the gallbladder appear empty (collapsed) because there is no bile flow out of the liver anxiety 6 year old purchase 150 mg effexor xr free shipping. In patients with distal cholangiocarcinoma anxiety 3 year old order effexor xr without a prescription, ultrasound demonstrates dilated intra and extrahepatic ducts along with significant dilation of the gallbladder anxiety 4 year old boy purchase cheap effexor xr. Peripherally located tumors cause segmental or lobular obstruction of the biliary tree anxiety symptoms teenagers purchase effexor xr line. Extrahepatic bile ducts and the gallbladder appear normal (filled with bile) in patients with peripheral cholangiocarcinoma anxiety symptoms upper back pain effexor xr 75mg mastercard. Transabdominal ultrasound can also detect the presence of liver metastases as single or multiple rounded lesions of different echogenicity. Similar to transabdominal ultrasound, computed tomography produces different pictures depending on location of the tumor and the level and degree of obstruction. Distal tumors produce universal dilation of intra and extrahepatic bile ducts and gallbladder. Peripheral cholangiocarcinoma may present with atrophy, decreased size of the affected lobe of the liver with minimal dilation of the small intrahepatic ducts. In contrast to hypervascular hepatocellular carcinomas, cholangiocarcinomas are usually hypovascular and appear hypodense or isodense compared to liver parenchyma. Computed tomography is also capable of demonstrating the presence of liver metastases or lymphatic nodules and tumor growth into surrounding organs. The recent addition of magnetic resonance cholangiography allows visualization of both dilated biliary ducts proximal to the tumor and normal-sized extrahepatic ducts distal to the level of occlusion. Ductal or intravenous injection of contrast medium is not necessary and the patient is not exposed to irradiation. Endoscopic Diagnosis Gastrointestinal endoscopy allows the physician to visualize and biopsy the mucosa of the upper gastrointestinal tract. The enteroscope allows visualization of at least 50% of the small intestine, including most of the jejunum and different degrees of the ileum. During this procedure, the patient may be administered a pharyngeal topical anesthetic agent that helps to prevent gagging. The side-viewing endoscope is introduced into the second portion of duodenum, and contrast material is injected into the bile ducts via major duodenal papilla under fluoroscopic guidance (Figure 14). Multiple x-ray pictures are taken to visualize the distribution of the contrast in the biliary tree. Endoscopic retrograde cholangiopancreatography can demonstrate normal diameter and structure of the extrahepatic ducts distal to occlusion and dilated intrahepatic ducts proximal to occlusion (Figure 15). These blood clots, if not removed, can be misleading in terms of demonstrating the true size and extent of the tumor into the lumen of bile ducts. Samples of tissue from the tumor can be obtained during the procedure by brush or biopsy under fluoroscopic guidance to confirm the diagnosis (Figure 17). This group of patients would benefit from percutaneous transhepatic cholangiography. Brush biopsy of a cholangiocarcinoma; A, cholangiogram; B, corresponding illustration showing the brush catheter. The procedure is performed after the patient has been prepared (the same as for standard upper endoscopy). Topical anesthesia and intravenous sedation are administered and the scope is passed through the mouth and into the stomach. Endoscopic ultrasound has been used for the diagnosis of carcinomas of the bile duct. This technique has been used to stage carcinomas of the bile duct and the gallbladder. A, Location of the endoscope in duodenal bulb; B, corresponding cross-sectional view; C, corresponding ultrasound image. Percutaneous Radiological Diagnosis Percutaneous Transhepatic Cholangiography Percutaneous transhepatic cholangiography is an invasive procedure performed by a radiologist under fluoroscopic guidance. A small needle is introduced through the liver into one of the peripheral biliary ducts. Contrast material is injected through the needle and x-ray pictures obtained to document the biliary tree anatomy. If cholangiocarcinoma causes complete obstruction of the biliary tree, percutaneous transhepatic cholangiography is the ideal method to visualize the ducts proximal to obstruction. Bile ducts distal to obstruction may not be visible on percutaneous transhepatic cholangiography in this situation (Figure 19). A, Technique of transhepatic percutaneous cholangiography; B, corresponding percutaneous cholangiograph (after catheter is introduced). It is used to evaluate the level of biliary obstruction and to assess resectability and invasion of the portal vein and/or hepatic artery. This procedure detects vascular encasement (seen as gradual narrowing of the vessel with irregular borders), venous obstruction (complete obliteration of the lumen), and also aids in the delineation of anatomy, prior to surgical resection. Angiography is an accurate means of diagnosing mesenteric vascular disease, portal hypertension and gastrointestinal hemorrhage. During the procedure, blood pressure, electrocardiogram, oxygen saturation and pedal pulses are monitored. There may be some slight discomfort at the puncture site, as well as a burning sensation during contrast injection. After four hours of observation, patients are ambulated and discharged (often with an attendant). Surgical approaches have become increasingly aggressive over the last decade since it has become apparent that curative treatment is dependent upon aggressive excision. Operative mortality in the hands of an experienced surgeon is extremely low (close to 0% for local resections and less than 10% for procedures with hepatic resection). Treatment of hilar cholangiocarcinoma requires resection of the bifurcation of common hepatic duct. The procedure starts with exploration of the peritoneal cavity to detect possible dissemination and resectability of the tumor. If the cholangiocarcinoma appears resectable, the gallbladder should be mobilized and the distal common bile duct divided. Careful dissection continues proximally until right and left hepatic ducts are separated above the tumor. Biliary reconstruction is achieved through bilateral hepatojejunostomy on a Roux-en-Y intestinal loop above the transhepatic silicone biliary stents. If cholangiocarcinoma extensively involves one lobe of the liver and relatively spares the other lobe, resection of the affected lobe or caudate lobe may be warranted with subsequent unilateral (in case of resection of right or left hepatic lobectomy) or bilateral (in case of caudate lobe resection) hepatojejunostomy (see Figures 21 and 22). Surgical treatment of peripheral cholangiocarcinoma is similar to hepatocellular carcinoma and requires hepatic lobectomy or segmentectomy depending upon the size of the tumor. Dissection of the hepatic ducts confluence and reconstructive hepatojejunostomy is not necessary after resection of peripheral cholangiocarcinoma. For tumors of the proximal third of extrahepatic ducts, surgery usually includes resection of the tumor with subsequent hepatojejunostomy (Figure 21 and 22). A, B, Surgical technique for bilateral hepatojejunostomy with Roux-en-Y anastomosis for the removal of an extrahepatic tumor. A, B, Surgical technique for unilateral hepatojejunostomy with Roux-en-Y anastomosis and left hepatic lobectomy. For tumors of the middle third of extrahepatic duct, surgical options include resection of the mass with possible primary end-to-end bile duct anastomosis (for early small tumors) or hepatojejunostomy (if large portion of extrahepatic ducts should be removed). For tumors located in distal common bile duct, the Whipple procedure is recommended (same as for ampullary tumors). Whipple procedure with variations of the final anastomosis: hepatojejunostomy, duodenojejunostomy, and pancreaticojejunostomy to restore continuity of the gastrointestinal tract. Surgery remains the primary treatment of cholangiocarcinoma, even for advanced stages of the tumor. Resectability of the tumor and survival rates in patients with cholangiocarcinoma depend on location of the tumor and spread of the disease at the time of presentation. Survival rates are higher in specialized institutions where a multidisciplinary team, including surgeon, oncologist, endoscopist, interventional radiologist and supporting staff are involved. Reported resectability increased with the more distal location of the tumor (50% for peripheral cholangiocarcinoma vs. Five-year survival rates for resected peripheral, hilar and distal cholangiocarcinoma were 44%, 11% and 28%, and median survival rates were 26, 19, and 22 months, respectively. Endoscopic Therapy Endoscopic biliary dilation may be used as a final palliative measure to relieve jaundice in patients who are poor surgical candidates, or as one of the steps prior to surgical intervention. This procedure requires use of a side-viewing endoscope to access the biliary duct and to introduce an inflatable balloon or series of endoscopic dilators over a guide wire. In many cases, a biliary sphincterotomy is performed prior to dilation and stent placement. After successful dilation, plastic or self-expanding metal stents (endoprostheses) may be placed into the biliary ducts. Plastic stents should be replaced endoscopically at regular intervals (usually 8?12 weeks). In case of complete obstruction of biliary ducts, it may not be possible to advance an endoscopic guide-wire above the occlusion. Radiological Therapy Percutaneous transhepatic palliative biliary dilation is performed by an interventional radiologist and requires transcutaneous puncture of the peripheral bile ducts and the subsequent placement of 12?16 French polymeric catheters. In patients with hilar cholangiocarcinoma occluding both the right and left hepatic ducts, separate percutaneous tubes may be inserted into right and left biliary systems and advanced through the side of occlusion into the duodenum, if possible. Percutaneous polymeric biliary stents are usually exchanged at regular intervals to prevent occlusion and infectious complications. Percutaneous self-expandable metallic stents are recommended as a definitive method of palliation in patients with cholangiocarcinoma who are not surgical candidates (Figure 28). Right and left percutaneous self-expandable metal stents restore patency around a hilar tumor. Other Therapeutic Approaches Chemotherapy and Radiotherapy Currently, no chemotherapeutic approach has been shown to positively affect the clinical outcome in patients with cholangiocarcinoma. Reports on long-term survivors after radiotherapy have shown that some individuals may benefit from treatment, but potential complications are significant (duodenitis, bile duct stenosis, duodenal stenosis). Encouraging results have been demonstrated using interstitial or intraoperative radiation. Internal radiation or brachytherapy may be useful as adjuvant therapy following surgery or as a palliative therapy in combination with biliary enteric bypass. In unresectable cholangiocarcinoma, the therapeutic strategy is to improve cholestasis by placing an endoprosthesis across the tumor, or by performing a biliary bypass. These procedures do not affect tumor growth, and it is unclear if they improve survival. However, improvement of cholestasis does improve symptoms such as fatigue, diarrhea, anorexia, pruritis, jaundice and sleep pattern, thus improving quality of life. Because early morbidity and 30-day mortality is significantly higher with surgical procedures than endoscopic/percutaneous drainage, such interventional techniques are preferable. Independent of the type of stricture, technically successful endoprosthesis placement can be achieved in 84-96% of these patients. Insertion of permanent metal endoprosthesis improves occlusion rates and reduces the number of therapeutic interventions; however, does not lessen median survival time. Chemotherapy and radiotherapy (external-beam radiotherapy and 192I brachytherapy) have been used to decrease tumor growth rates, however, no randomized prospective trial evaluating the effects of these therapies has been conducted. A retrospective study comparing palliative endoscopic stenting versus stenting combined with radiotherapy showed no significant difference in median survival time. Studies with chemotherapy are not interpretable because they include different liver malignancies and therapeutic regimens. The question remains whether additional radiotherapy or chemotherapy is of benefit to patients with unresectable cholangiocarcinoma. A photosensitizer is administered and selectively retained by the target tumor tissue. The photosensitizer is nontoxic in its native state, however, after activation by a light at a particular wavelength, the photosensitizer becomes cytotoxic and produces local tissue destruction. The only relevant side effect seen to date is phototoxicity, which lasts often for 4-6 weeks after drug administration. Ninety-six percent of patients improved in terms of cholestasis, performance and quality of life. The apparent benefit in survival time, however, needs to be confirmed with randomized, controlled trials. Ofcial Medicare Program legal guidance is contained in the relevant statutes, regulations, and rulings. It includes information on how and when you can get these benefts and how much you?ll pay. If you have a question about a test, item, or service that isn?t listed in this booklet, visit Medicare. If you have a Medicare Advantage Plan or other Medicare health plan, you have the same basic benefts as people who have Original Medicare, but the rules vary by plan. Some services and supplies may not be listed because the coverage depends on where you live. In 2020, you pay a yearly $198 deductible for Part B-covered services and supplies before Medicare begins to pay its share, depending on the service or supply. Assignment is an agreement by your doctor, provider, or supplier to be paid directly by Medicare, to accept the payment amount Medicare approves for the service, and not to bill you for any more than the Medicare deductible and coinsurance. Depending on the service or supply, actual amounts you pay may be higher if doctors, other health care providers, or suppliers don?t accept assignment. Doctors who don?t accept assignment may charge you more than the Medicare-approved amount for a service, but they can?t charge more than 15% over the Medicare-approved amount for non participating doctors.

Centers for Disease Control: Recommendations for prevention infection during invasive dental procedures-Florida anxiety 4am cheap effexor xr 150mg fast delivery. Update: universal precautions for prevention of transmission transmission to patients and prevention issues anxiety symptoms stomach 150mg effexor xr sale. J Am Dent Assoc of human immunodefciency virus anxiety 1894 by edvard munch buy effexor xr 37.5 mg online, hepatitis B virus anxiety symptoms skipped heart beats order effexor xr 150mg with amex, and other 1983;106:219-222 anxiety level test purchase effexor xr with a visa. Public Health Service guidelines for the management of for carcinoma of the breast symptoms 9f anxiety buy effexor xr 150 mg low price. Centers for Disease Control: Update: human immunodefciency infective endocarditis or infected prosthesis during colon and virus infections in health-care workers exposed to blood of rectal endoscopy. Antibiotic prophylaxis for dental patients exposures to human immunodefciency virus type 1. Am J 2008 guideline update on valvular heart disease: focused update Gastroenterol 1997;92:989-991. Practice parameters for antibiotic prophylaxis of Cardiology/American Heart Association Task Force on to prevent infective endocarditis or infected prosthesis during Practice Guidelines: endorsed by the Society of Cardiovascular colon and rectal endoscopy. Acute compartment endocarditis: guidelines from the American Heart Association: a syndrome of the leg following diagnostic electromyography. Compartment syndrome of the Cardiovascular Disease in the Young, and the Council on Clinical forearm following an electromyographic assessment. J Hand Cardiology, Council on Cardiovascular Surgery and Anesthesia, Surg Br 2005;30:656-657. Risk of hematoma following needle electromyography muscles: case report and radiographic analysis. Complications of needle electromyography: hematoma risk and correlation with anticoagulation and antiplatelet therapy. Risk factors for stroke and effcacy of antithrombotic therapy in atrial fbrillation. The first is venous edema, caused by increased capillary Treating the underlying cause can often lessen the edema. Regardless of the mechanism, chronic bilateral pedal Acute onset and presence of edema for less than 72 hours edema is detrimental to the health and quality of life of suggests the possibility of venous thrombosis and steps older adults. Besides alterations in cosmetic appearance or should be taken to exclude that diagnosis. Edema due to the discomfort it may cause, older adults with pedal edema chronic venous insufficiency is often associated with a dull often experience gait disturbance with decreased mobility aching pain. In contrast, lymphedema, which is often due and increased risk of falls, impairment of sensation in the to obstruction, is usually painless. If the cause of edema is not identified with the history and Evaluation physical exam, further studies should be performed. To When evaluating a patient with pedal edema, it is rule out systemic disease, a complete metabolic panel, important to distinguish between unilateral and bilateral complete blood count, thyroid stimulating hormone, and disease. In the long term, it is more important to address and reverse the process causing the edema. Consider zippered stockings if patients have difficulty putting on non-zippered stockings, and use liners to prevent pinching the skin. Do not rely on pedal pulses to decide if patients with pedal edema have peripheral arterial disease. If heart failure or pulmonary hyper graded) should not be used to treat pedal edema in pa tension with sleep apnea are suspected, an echocardiogram tients who have uncontrolled heart failure, severe or oozing should be obtained. This the lymph system are stimulated with the hands, either by a is typically accomplished by non-pharmacologic treatments therapist or by patients themselves. Preventive measures should be employed to reduce compli Non-Pharmacologic Treatment of Pedal Edema cations of chronic edema. In particular, patients and their caregivers should be taught how to lower the risk of celluli Treatment Mechanism of Action tis/erysipelas through good skin hygiene, and how to recognize the signs of infection early should they occur. Exercise Muscle activity stimulates contrac tility of lymph vessels and encour Modification of sodium or protein intake is sometimes rec ages cranial movement of lymph ommended. There is little evidence to support its benefit, however, unless part of the treatment regimen for a sys Elevation Decreases venous filtration by temic condition causing the edema. However, the first step in drug treatment is, if compression (hosiery) keeping fluid in venous system possible, to decrease or stop current medications that may be contributing to edema (Table 1). Lymphatic massage Stimulates lymph drainage to If diuretics need to be administered as a treatment for pe flow proximally dal edema, they are most appropriate for short term use to aid in initial excretion of excess fluid. Longer-term ad If external compression stockings are used, they should be ministration of diuretics may, however, also be appropriate graded. If patients if their use is aimed at treating the underlying cause of the struggle with putting on the stockings, stockings that come edema. Use of non-graded the mainstay of therapy for treating edema itself in the hosiery. Non-graded hosiery is ap should be monitored for dehydration and electrolyte dis propriate, however, for use in patients with a history of turbances, both of which are potential risks when diuretics deep venous thrombosis to prevent recurrent clot formation. Guidelines Pneumatic devices are covered for the treatment of lymphedema or for the treatment of chronic venous insufficiency with venous stasis ulcers. Secondary lymphedema, which is much more common, results from the destruction of or damage to formerly functioning lymphatic channels, such as surgical removal of lymph nodes or post radiation fibrosis, among other causes. Pneumatic compression devices are covered in the home setting for the treatment of lymphedema if the patient has undergone a four-week trial of conservative therapy and the treating physician determines that there has been no significant improvement or if significant symptoms remain after the trial. The trial of conservative therapy must include use of an appropriate compression bandage system or compression garment, exercise, and elevation of the limb. The garment may be prefabricated or custom-fabricated but must provide adequate graduated compression. The trial of conservative therapy must include a compression bandage system or compression garment, appropriate dressings for the wound, exercise, and elevation of the limb. General Coverage Criteria Pneumatic compression devices are covered only when prescribed by a physician and when they are used with appropriate physician oversight, i. The clinical response includes the change in pre-treatment measurements, ability to tolerate the treatment session and parameters, and ability of the patient (or caregiver) to apply the device for continued use in the home. Pneumatic compression devices for the prevention of illness/disease including venous thromboembolism. Items and services which are not reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member are not covered. The law requires that a physician must document that a physician, nurse practitioner, physician assistant or clinical nurse specialist has had a face-to-face encounter with the patient. Note that the date of the written order must not be prior to the date of the face-to-face encounter. Listing of a code in this guideline does not imply that the service described by the code is a covered or non-covered health service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage for a specific service. It is expected providers retain or have access to appropriate documentation when requested to support coverage. Please utilize the links in the References section below to view the Medicare source materials used to develop this resource document. This document is not a replacement for the Medicare source materials that outline Medicare coverage requirements. Where there is a conflict between this document and Medicare source materials, the Medicare source materials will apply. These Policy Guidelines are provided for informational purposes, and do not constitute medical advice. Treating physicians and healthcare providers are solely responsible for determining what care to provide to their patients. Members should always consult their physician before making any decisions about medical care. Benefit coverage for health services is determined by the member specific benefit plan document* and applicable laws that may require coverage for a specific service. The member specific benefit plan document identifies which services are covered, which are excluded, and which are subject to limitations. In the event of a conflict, the member specific benefit plan document supersedes the Medicare Advantage Policy Guidelines. Medicare Advantage Policy Guidelines are developed as needed, are regularly reviewed and updated, and are subject to change. They represent a portion of the resources used to support UnitedHealthcare coverage decision making. UnitedHealthcare may modify these Policy Guidelines at any time by publishing a new version of the policy on this website. Medicare Advantage Policy Guidelines are intended to ensure that coverage decisions are made accurately based on the code or codes that correctly describe the health care services provided. Unauthorized copying, use and distribution of this information are strictly prohibited. Spain; 2Department of Dermatology and bruising existing almost exclusively among women. Early diagnosis and treatment are mandatory accepted 14 June 2012 for this disorder otherwise gradual enlargement of fatty deposition causes impaired mobility and further comorbidities like arthrosis and lymphatic insuf? However, we found two documents in the lence of lipedema, Foldi described a prevalence of 11% in Cochrane Library (10). According to our experience, in different databases: Web of Knowledge (13), Scopus from 843 patients seen in the unit since 2005, lipedema (14), Cochrane Library (10) and Embase (12). The search in the databases provided us 46 documents after Clinical manifestations of lipedema excluding 19 repeated or redundant papers, two articles in Chinese, two in Serbian, one in Russian, 12 with a different Lipedema is de? The enlargement text through full-text resources or asking directly to the of the lower limbs is disproportionate in relation to the author. The analysis of these documents reveals the increasing Patients complain that edema in lower limbs may worsen interest on the subject and that most have been written in in the afternoon or evening and that increased swelling is Germany being a highlighted topic in the scienti? Most of the articles are sensitivity to pain and spontaneous or minimal trauma reviews from others and original research is scarce. As lipedema progresses, increasing lower pain on palpation and frequent bruises occurring sponta limb weight may lead to hip and knee joint damage that can neously or provoked by minimum blows due to capillary develop to orthopaedic disorders and gait alterations with fragility. Lipedema often co-exists with obesity and the patients report spontaneous or even minimal pressure clinical diagnosis may be confused as simply obesity. Diagnosis Lipedema is distinguished from obesity because it usually Diagnosis of lipedema is usually made on the basis of appears in lower limbs, more rarely in arms, whereas clinical features (20). The most lipedema (32): common locations of painful fatty depositions are the limbs, trunk, the pelvic area and the buttocks (27,28). Other radiological examinations may also help in the differential diagnosis of lipedema. Skin thickening can appear in lipedema, but subcu Stage I: the skin surface is normal and the subcutane taneous? The Lymphoscintigraphy can be useful in the differential nodules vary in size and can be distinguished from the diagnosis of edema, allowing the exclusion of clear lym surrounding tissue on palpation. Based on the result of Streeten test together tous adipose tissue with loss of adipocytes due to necrosis with clinical features, the diagnosis of lipedema can be and simultaneous proliferation of adipose-derived stem suspected (34,35). These results suggest massive adipo Duplex ultrasound examination of lipedema shows a genesis with concomitant hypoxia resulting in necrosis and thickened subcutis with increased echogenicity, whereas in macrophage recruitment (48). The German Phlebological Society recommends the volume of the limb by diminishing the persistent lymph liposuction as a part of therapeutic armamentarium in the stasis, increases protein resorption and opens lymphatic management of lipedema (17). It improves pre volume of the limb (60), emphasizing the use of compression dominantly venous? One uncontrolled trial of complex decongestive liposuction results the most potent bene? Each treatment modality Current knowledge about lipedema as a hidden epidemic is resulted in signi? Management of lower limb sial, however, lipedema remains a relative contraindication lymphoedema in the United Kingdom. Eur J Vasc Endovasc Surg to varicose vein surgery because it may worsen swelling 2006; 31: 311?315. Phle lymphologischen fachklinik erscheinungsformen, mischbilder bologie 2000; 29: 124?128. High resolution unenhanced computed tomography in patients and treatment possibilities]. Lipedema: an inherited ferential diagnosis, investigation, and current treatment of lower condition. Exp Clin Endocrinol Diabetes 2010; 118: agnosed and misunderstood fatty deposition syndrome. Commissioner January 10, 2018 For further information concerning this document contact: Bob Morrow, Associate Commissioner, Life & Health Maryland Insurance Administration 200 St. As proposed, this bill would provide a new mandated benefit standard requiring an insurer, nonprofit health service plan, or health maintenance organization that provides hospital, medical, or surgical benefits to provide coverage for the medically necessary diagnosis, evaluation, and treatment of lymphedema including equipment, supplies, complex decongestive therapy, gradient compression garments, and self-management training and education. It is important to note that NovaRest also spoke with providers who disagreed that carriers are providing coverage to the extent represented in this report. The goal of this Workgroup was to pinpoint the gaps in coverage, as well as the gaps in provider and consumer knowledge about the coverage, and determine what actions may be needed to ensure that lymphedema patients receive coverage for medically necessary treatment. The Workgroup held two public meetings in September 2017 to gather both information and insight into the issues affecting consumers and providers. The Workgroup heard from lymphedema therapists, durable medical equipment vendors, lymphedema patient advocates, and an anesthesiologist. One insurance carrier representative provided testimony on behalf of the insurance carrier. After the public meetings, the Workgroup put together a survey designed to build upon the work of the NovaRest survey conducted in 2016. When NovaRest references six carriers in its report, it appears to be referencing carrier groups, not the individual statutory entities. These included the definition of lymphedema, the stages of lymphedema, lack of lymphedema knowledge by providers and consumers, and the treatment of lymphedema.

Generic effexor xr 75mg line. What is Social Anxiety Disorder? Mental Health Help with Kati Morton treatment scared school.

The evaluating provider must decide whether further workup However anxiety synonyms discount 37.5 mg effexor xr with mastercard, the logistical and? The purpose of hospital-based acceptance of syncope units requires further evidence of evaluation is to expedite the treatment of identi? Individual risk factors conditions or to continue the diagnostic evaluation in the (Table 5)andriskscores(Table 6) are correlated with short and 105 anxiety symptoms generalized anxiety disorder effexor xr 37.5 mg visa,106 long-term clinical outcomes anxiety disorder nos order 75mg effexor xr with mastercard, but they are not primary determi absence of a presumptive cause of syncope anxiety relief buy cheap effexor xr 150mg online. The disposition decision is complicated by varying re nants for admission to hospital anxiety fear order effexor xr paypal. Presence of 1 serious medical sources available for immediate testing anxiety symptoms yahoo generic 150 mg effexor xr mastercard, a lack of consensus condition, summarized in Table 7, is the key determinant for 90,98 on acceptable short-term risk of serious outcomes, varying further in-hospital management of patients after syncope. Finally, a large spectrum of noncardiac serious conditions may be associated with syncope and require management of the underlying problem. Both trials also allowed unstructured physician judgment to identify intermediate-risk patients. A broad-based use of additional testing the selection of a given diagnostic test, after the initial history, is costly and often ineffective. See Figure 3 for the algorithm for and a clear understanding of diagnostic and prognostic value additional evaluation and diagnosis for syncope. This section reviews circulating biomarkers, which the availability of simple and accurate biomarkers might are being evaluated as markers either of hypotension or under streamline risk strati? Complete blood count and electrolyte panel are frequently obtained during syncope evaluation. The diagnostic yield is low when these are used routinely; however, when these blood tests are conducted in patients with a suspected related diagnosis. See Online Data Although data to support biomarker testing are in general relatively weak, there are suf? There is little biological plausibility linking the remaining elements of broad-panel laboratory testing to the presentation or mechanism of syncope. Cardiovascular Testing: Recommendations the abnormalities found during cardiovascular testing may Cardiovascular causes of syncope are common. As such, cardiovascular testing can be a critical element in the evaluation and management of selected cardiovascular testing. Transthoracic echocardiography can be useful when healthcare providers are concerned about the presence of valvular disease. Although an echocardiogram may not be able to establish the immediate cause of syncope, it provides information for a potential disease substrate related to prognosis. These modalities offer superior spatial resolution in delineating cardiovascular anatomy. They provide information on the structural disease substrate relevant to the overall diagnosis and subsequent evaluation and follow-up in selected patients presenting with syncope. Subjecting a patient to a treadmill exercise test to reproduce the symptoms or evaluate the hemodynamic response to exertion. However, bradyarrhythmia may ultimately be responsible for exertional syncope as well, and may only be elicited during stress testing. Cardiac Monitoring: Recommendations the choice of monitoring system and duration should be Although cardiac monitoring is often used in the evaluation appropriate to the likelihood that a spontaneous event will of palpitations or intermittent arrhythmias, the following rec be detected and the patient may be incapacitated and unable ommendations and discussion are focused primarily on the to voluntarily trigger the recording system. N/A the technology of cardiac rhythm monitoring is dynamic and advancing at rapid speed. Their selection and usefulness are highly dependent on patient characteristics with regard to the frequency of syncope and the likelihood of an arrhythmic cause of syncope. The effectiveness of any external cardiac Supplements monitoring device for syncope evaluation is related to the duration of monitoring, continuous versus intermittent 11 and 12. The patient activation, before or after an event, allows for symptom rhythm correlation; however, some external loop recorders are of limited use inpatientswhoare temporarilyincapacitatedaroundthetimeof syncope. Theadvantageofanexternal looprecorderoverHoltermonitoringstemsfromalonger 149,153 monitoring period, which confers a higher yield than Holter monitoring and may offer a diagnosis after a negativeHolterevaluation. One prospective, multicenter study of 392 patients (28% with syncope) reported a 4-week diagnostic yield of 24. The advances of new patch-based devices offer another and often less cumbersome means of identifying an arrhythmic cause for syncope. Some practices offer mobile continuous outpatient telemetry devices, which provide real-time arrhythmia monitoring and analysis. Importantly, there was a similar result in the subgroup of patients presenting with syncope or presyncope, with a signi? Table 8 Cardiac Rhythm Monitors Types of Monitor Device Description Patient Selection 151?153 Holter monitor A portable, battery-operated device Symptoms frequent enough to be detected Continuous recording for 24?72 h; up to 2 wk with newer within a short period (24?72 h) of monitoring* models Symptom rhythm correlation can be achieved through a patient event diary and patient-activated annotations Patient-activated, A recording device that transmits patient-activated data (live Frequent, spontaneous symptoms likely to recur transtelephonic or stored) via an analog phone line to a central remote within 2?6wk monitor (event monitoring station. However, the diagnostic yield of inpatient telemetry is low in the absence of high suspicion about an arrhythmic cause. In 1 prospective study of 2,240 patients admitted to a telemetry unit, patients admitted for syncope (10%) had low rates of unexpected intensive care transfer, and most were unrelated to arrhythmic conditions. A large, prospective evaluation of 2,106 patients admitted with syncope demonstrated high telemetry use (95%) but a diagnostic yield of only 5%. Electrophysiological Study: Recommendations or with low suspicion of an arrhythmic etiology. The hemodynamic response to the tilt maneuver determines 214 whether there is a cardioinhibitory, vasodepressor, or mixed response. There is general consensus that a tilt-table angle of 70 degrees for 30 to 40 minutes would provide optimal yield. Prolonged convulsions and marked postictal confusion are uncommon in patients with syncope associated with convulsive movements,226 and fatigue is frequent after re? Tilt-table testing has been shown to be of value in this clinical setting when a detailed history cannot clearly determine whether the convulsive movements were secondary to syncope, given the need for objective evidence to help distinguish this entity from true epileptic seizures. In a prospective study of 15 patients with recurrent unexplained seizure-like episodes who were unresponsive to antiepileptic therapy,223 67% had convulsive movements associated with hypotension and bradycardia during tilt-table testing. In another study of 74 patients with a questionable diagnosis of epilepsy (because of drug-refractory seizures or clinically suspected not to be true epilepsy), a cardiac diagnosis was established in 42% of patients, with. Neurological Testing: Recommendations persistent and often progressive generalized weakness, fa tigue, visual blurring, cognitive slowing, leg buckling, and 3. These symptoms central or peripheral autonomic nervous system damage or may be provoked or exacerbated by exertion, prolonged dysfunction. Such care may be provided by a neurologist, cardiologist, internist, or other physician who has suf? The evidence suggests that routine neurological Recommendations testing is of very limited value in the context of syncope eval Many patients undergo extensive neurological investigation uation and management; the diagnostic yield is low, with 36,77,78,251?260 after an uncomplicated syncope event, despite the absence very high cost per diagnosis. Management of Cardiovascular Conditions vant to and within the context of the speci? Arrhythmic Conditions: Recommendations isting guideline recommendations in the present guideline, Cardiac arrhythmia is a common cause of syncope, and the except for the speci? Management of paroxysmal and occult on initial evaluation?poses addi patients with syncope and heart disease would include treat tional challenges and may warrant a more extensive evalua ing the immediate cause of syncope and further assessing tion (Section 3. The evidencecontinuestosupport,withoutchangefromthepreviousrecommendation,thenotionthatpermanentpacemakerimplantation is reasonable for syncope in patients with chronic bifascicular block when other causes have been excluded. The use of adenosine triphosphate in the evaluation of syncope in older patients continues to evolve. The writing committee has reached a consensus not to make a new recommendation on its use for syncope evaluation because of the limited data at this time. If new published data were of syncope is discussed in patients with underlying structural available, they were incorporated into the present document. A review of evidence supports previously published recommendations for patients with syncope in the presence of underlying cardiomyopathy. The mechanism is often hemodynamic, as opposed to arrhythmic, because of inability to augment and sustain cardiac output. In patients with valvular heart disease causing syncope, treatment is recommended by the latest guidelines. Inheritable Arrhythmic Conditions: of death in the patients with inheritable rhythm disorders, 25,26,220 Recommendations its impact on syncope recurrence is unknown. The prevalence of inherited arrhythmic conditions is low, rendering the clinical signi? Most of with type 1 morphology 2mmin 1 lead among the the publications included other cardiac events, such as car right precordial leads V1 and V2, occurring either sponta diac arrest and death, either at enrollment or as an neously or after intravenous administration of Class I anti outcome. The response to beta blockers depends on the genotype, and not all beta blockers are the same. See Online Data Cardiac events can occur in patients receiving beta-blocker therapy, with a prevalence ranging from 10% to 32%, Supplement 21. Careful programming, including long detection intervals with high cutoff rate, is recommended to decrease the prevalence of inappropriate shocks. Early Repolarization Pattern: Recommendations studies to be associated with increased risk of cardiac Early repolarization pattern is characterized by a distinct J 352,353,355?357 death. In patients with syncope, the clin lateral leads occurs in 1% to 13% of the general population ical signi? Preliminary 361?365 data from cardiac ganglia plexi ablation in treating selected pa emotional stress, pain, or medical procedures. See Online Data Patients with a syncope prodrome should be instructed to assume a supine position to prevent a faint and Supplements minimize possible injury. In a randomized, parallel, open-label trial, leg crossing with conventional therapy. Patients undergo repetitive tilt-table tests in a monitored setting Supplements until a negative tilt-table test occurs and then are encouraged to stand quietly against a wall for 30 to 60 minutes 25 and 26. See Online Data Fludrocortisone has mineralocorticoid activity resulting in sodium and water retention and potassium excretion, which Supplements 25 and 26. Care should be taken to withdraw or reduce medications only where safe to do so and in conjunction with the prescribing healthcare provider. Pacemakers in Vasovagal Syncope: vasodepressor response may increase the likelihood of a Recommendation response to pacing. It is becoming clear that strict patient selection on the basis of documented asystole during dence, the results of which were used to frame our decision clinical syncope is important, and that observation making. Carotid Sinus Syndrome: Recommendations Carotid sinus syndrome is associated with mechanical manipulation of the carotid sinus, either spontaneously or 5. It occurs determine an underlying etiology, including causes that 413,414 431,433?436 more commonly in men. Treatment of most types of should be performed sequentially over the right and left situational syncope relies heavily on avoidance or carotid artery sinus in both the supine and upright positions elimination of a triggering event. This may not always be for 5 seconds each, with continuous beat-to-beat heart rate possible, so increased? Contraindi 436 cations to performing carotid sinus massage include ausculta encouraged where appropriate and safe. Orthostatic Hypotension: Recommendations myocardial infarction within the prior 3 months, except if ca 418 6. With standing, venous return 31 Recommendations for Carotid Sinus Syndrome to the heart drops, with a resultant decrease in cardiac output. In some individuals, this response may be defective or reasonable in patients with 31 carotid sinus syndrome inadequate. Other side effects commonly seen include edema, hypokalemia, and headache, but more serious adverse reactions, such as adrenal suppression and immunosuppression, can also occur with doses. Dehydration and Drugs: Recommendations spectrum of symptoms, ranging from tachycardia to shock, Syncope related to medication becomes prevalent particularly depending on whether a person has compensated or 494 in older adults, who frequently have multiple comorbidities uncompensated hypovolemia. Orthostatic tolerance requiring treatment and are prone to polypharmacy ef worsens with dehydration and is exacerbated by heat stress, 488?490 495?497 fects. Rehydration, whether key for symptomatic improvement, but often feasibility of by intravenous or oral formulation, should include sodium 21,498?501 cessation of medications is limited by the necessity of the supplementation for more rapid recovery. The Supplements 36 latter is likely due to peripheral vasodilation and vasovagal physiology. Orthostatic Intolerance to be a conversion disorder?in essence, an external somatic Orthostatic intolerance is a general term referring to frequent, manifestation or response to internal psychological stresses. Most commonly, the symptoms include lightheadedness, palpita clinical distinction between the two is based on whether prom tions, tremulousness, generalized weakness, blurred vision, inent jerky muscle movements simulating seizure activity are exercise intolerance, and fatigue. In the absence of associated jerky move accompanied by hemodynamic disturbances, including ments, the patient is likely to be referred for evaluation of syn 30,229,524 blood pressure decrease, which may or may not meet criteria cope. Although many patients with pseudo Psychogenic pseudosyncope is a syndrome of apparent loss of syncope can be diagnosed with a careful history, occasionally consciousness occurring in the absence of impaired cerebral tilt-table testing with or without transcranial Doppler and moni perfusion or function. See Online Data Uncontrolled studies suggest that psychotherapy, particularly cognitive behavioral therapy, may be bene? Uncommon Conditions Associated With nosis or a complete synopsis of all conditions associated with syncope. Furthermore, it is not necessary to fully evaluate for Syncope Syncope has been reported in many uncommon diseases, ac all these causes when the etiology remains elusive. If the cause for syncope is unclear, these conditions could be predispose the patient to various types of syncope. Table 9 included in the differential diagnosis on the basis of other provides a list of less common conditions associated with clinical characteristics and/or historical features. It is not intended as a reference for differential diag Table 9 Conditions Uncommonly Associated With Syncope Condition Clinical Characteristics Notes Cardiovascular and cardiopulmonary Cardiac tamponade Hypotension, tachycardia, cardiogenic shock. Takotsubo cardiomyopathy540,541 Apical ballooning and basal hypercontractility, Syncope is uncommon and may be multifactorial. Pulmonary arterial hypertension Occurs more often during exertion in younger Syncope due to inability to augment or sustain patients.

Antifungal preparations with corticosteroids are classified in D01A Antifungals for topical use anxiety symptoms and treatments buy on line effexor xr. Corticosteroids anxiety symptoms panic attacks generic 150 mg effexor xr overnight delivery, antiseptics and salicylic acid in combination are classified in D07X symptoms of anxiety purchase effexor xr mastercard. Preparations with salicylic acid and antiseptics are classified in this group anxiety symptoms shivering order discount effexor xr line, as salicylic acid is regarded as being more important than the antiseptics for the therapeutic use of these products (psoriasis anxiety 9 year old daughter 150 mg effexor xr with amex, seborrhea) anxiety disorders purchase cheapest effexor xr and effexor xr. Other dermatological corticosteroid preparations are classified in D07 Corticosteroids, dermatological preparations. Other topical antiinfectives are classified in D06 Antibiotics and chemotherapeutics for dermatological use. Antibiotics, such as tetracyclines and erythromycin, which are also used for the treatment of acne, are classified in group J. Diclofenac formulated as a 3% hyaluronic acid gel used in treatment of actinic keratoses is classified here. Antivirals for topical use, including gynecological use, such as podophyllotoxin, are classified in D06 Antibiotics and chemotherapeutics for dermatological use. Other ergot alkaloids are classified in C04A Peripheral vasodilators, and in N02C Anti-migraine preparations. Similar adrenergic drugs, which are mainly used in the treatment of asthma, are classified in R03C. Cabergoline and bromocriptine tablets in higher strengths are classified in N04 Anti-Parkinson drugs. Sex hormones used only in the treatment of cancer (often selected strengths) are classified in L Antineoplastic and immunomodulating agents. Products containing mestranol (a prodrug of ethinylestradiol) are classified together with ethinylestradiol. Norethandrolone, which has both anabolic and androgenic effects, is classified in A14A since the anabolic effect is considered to be the most important effect. Combined preparations are included in this group, except combinations with female sex hormones, which are classified in G03E Androgens and female sex hormones in combination. Estrogens used only in neoplastic diseases, see L Antineoplastic and immunomodulating agents. Progestogens only used in neoplastic diseases, see L Antineoplastic and immunomodulating agents. Combination packages with separate tablets containing progestogens and estrogens intended to be taken together are also classified in this group. Combinations of progestogens and estrogens used as contraceptives are classified in G03A. Combination packages with separate tablets containing progestogens and estrogens intended to be taken together and in sequence are also classified in this group. Local anesthetic formulations for treatment of premature ejaculation are classified in N01B. Corticosteroids in combination with antiinfectives/antiseptics for local treatment of gynecological infections, see G01B. The antibacterials are classified according to their mode of action and chemistry. Combinations of antibacterials with other drugs, including local anesthetics or vitamins, are classified at separate 5th levels in the respective antibacterial group by using the 50-series. Inhaled antiinfectives are classified here based on the fact that preparations for inhalation can not be separated from preparations for injection. Combinations containing one penicillin and enzyme inhibitor are classified at different 5th levels according to the penicillin. The reference applied when defining generations is ?Principles and Practice of Infectious Diseases? by Mandell, Douglas and Benett, sixth edition, 2005. Combinations with beta-lactamase inhibitors are classified by using the 50-series. Limited activity against gram-positive cocci, particularly methicillin susceptible S. Preparations containing two or more sulfonamides are classified within the different 4th levels, using the 5th level code 20. In such combinations, the half-life of the most long-acting sulfonamide determines the classification. Preparations, which in addition contain a urine acidifier, such as vitamin C, calcium or ammonium chloride, are classified at the plain 5th levels. The two components have synergistic antibacterial effect and are always used together. Teicoplanin and intravenous preparations of vancomycin are classified in this group. Oral formulations and suppositories of imidazole derivatives are classified in P01 Antiprotozoals. Fosfluconazole (prodrug of fluconazole) is classified at the same 5th level as fluconazole. Combinations of vaccines within the same 3rd level are given separate 5th levels using the 50-series. Monovalent vaccines obtained from group A are classified at a separate 5th level, while other monovalent vaccines are classified together. Products containing oligosaccharides instead of polysaccharides may be included at each 5th level. The doses used vary substantially because of various types and severity of neoplastic diseases, and also because of the extensive use of combination therapy. The consumption of the antineoplastic agents is in some countries measured in grams. This is recommended as a method to be used internationally for these particular agents. This means that some strengths may be classified in this group, while remaining strengths are classified in G03 Sex hormones and modulators of the genital system. Dimethyl fumarate indicated for multiple sclerosis or plaque psoriasis is classified here. The substances in this group have a broad range of indications, however, they should be kept together in M01A. Exception: Salicylates in combination with corticosteroids are classified in M01B. Combined cold preparations with therapeutic levels of antiinflammatory agents are classified in this group at separate 5th levels by using the 50 series. The preparations are classified at 5th levels according to the anti inflammatory/analgesic component. Penicillamine, which is also used in conditions associated with impaired copper metabolism and as an antidot in copper poisoning, is classified in this group regardless of indication. Exception is a product containing diclofenac formulated as a 3% hyaluronic acid gel which is used in treatment of actinic keratoses. Combinations of non-steroidal antiinflammatory derivatives and other substances for topical use are classified together with plain preparations at the different 5th levels. Combined preparations containing nonivamide used as a rubefacient are classified in this group on a 4th level. Combinations of salicylic acid derivatives and other products are classified in this group. Combined preparations are classified at separate 5th levels using the corresponding 50-series (comb. These drugs are used in different conditions associated with pain and rigidity in the muscles, joints etc. Combinations used for cold conditions, containing quinine as an antipyretic, are classified in R05X. There are a number of combined preparations, which contain analgesics and psycholeptics. These are classified in N02, as pain relief must be regarded as the main indication. Combined preparations which contain more than one analgesic, should be classified by using the following ranking: 1. Cold preparations with therapeutic levels of analgesics are classified in this group at separate 5th levels by using the 50-series. Products containing less than 50 mg per unit dose are classified at the plain level of the analgesic component. Salicylic acid derivatives in combination with corticosteroids are classified in M01B. Dihydroergotamine, which is also used in the treatment of hypotension, is classified in this group. Combined preparations are classified at separate 5th levels using the corresponding 50-series. Phenobarbital, which is used both as an antiepileptic and as a sedative, is classified in this group. Antipsychotics in combination with antidepressants are classified in N06C Psycholeptics and psychoanaleptics in combination. The substances in this group are sometimes used for other indications in much lower doses. See also: N05A Antipsychotics N05C Hypnotics and sedatives Usually the presence of an anxiolytic (or other psycholeptics) in combined preparations must be regarded as being of secondary importance and the preparations should be classified in the respective therapeutic groups. Combined preparations used mainly for the treatment of anxiety are classified at separate 5th levels using the corresponding 50-series. Clonazepam used in the treatment of epilepsy is classified in N03 Antiepileptics. Regarding classification of combined preparations, see comments under N05B Anxiolytics. Combined preparations with barbiturates are mainly classified in A03 (mainly antispasmodic effect) or in N02 (mainly analgesic effect). Combined preparations with barbiturates which remain in N05C are mainly "neurostabilizers". Barbiturates used in general anesthesia are classified in N01A General anesthetics. The various antidepressants have different modes of action, and the classification will not reflect the exact mode of action of the various antidepressants. Psychostimulants, which cannot be classified in the preceding groups, are also classified here. Combined preparations with quinine for symptomatic relief in cold conditions are classified in R05X. Substances classified in this group are for topical use and the consumption figures for these preparations could be expressed in. See also R01B Nasal decongestants for systemic use, and R06 Antihistamines for systemic use. Most of the products classified in this group are combinations with antihistamines. Preparations used in common minor infections of mouth and throat are classified in R02, while preparations used in gingivitis, stomatitis etc. Preparations for the treatment of symptoms both in mouth and throat are classified in R02 Throat preparations. Dental anesthetics for local application are classified in N01B Anesthetics, local. It has been shown that certain inhalation devices give a better deposition of the active ingredient in the lungs. This gives a better clinical effect, and therefore the active ingredients can be used in lower dosages. For some substances, the labelling of the strength of identical inhalation products may differ between countries. In some countries, metered dose (measured as the amount of substance released from the inhaler with the mouthpiece removed) is used while in other countries delivered dose (measured as the amount of substance released from the inhaler with the mouthpiece in place) is used in the labelling. Cold preparations with therapeutic levels of analgesics/anti-inflammatory agents should be classified in the respective N02/M01 groups. Cold preparations with minimal amounts of analgesics are classified in R05X Other cold preparations. See also R01 Nasal preparations, R02 Throat preparations, and R03D Other systemic drugs for obstructive airway diseases. Combined preparations are classified at separate 5th levels using the code number 10. Other preparations used in motion sickness, see A04 Antiemetics and antinauseants. Combinations with expectorants R05C Combinations with nasal decongestants for systemic use R01B Combinations with cough suppressants R05D. Combinations with respiratory stimulants and caffeine are classified in this group. Systemic preparations with clear ophthalmological indications are also classified in this group. Small amounts of antiseptics in eye preparations do not influence the classification. Products containing boric acid, also in low strengths, are classified in this group. Combinations with antiinfectives are classified in S01C Antiinflammatory agents and antiinfectives in combination. Drugs used for producing miosis are classified in this group, even if the main indication is not glaucoma. In eye ointments one dose corresponds to about 10 mm (20 mg) per eye thus corresponding to 40 mg for both eyes.

References

• Blok BF, Sturms LM, Holstege G: Brain activation during micturition in women, Brain 121:2033n2042, 1998. Blok BF, Sturms LM, Holstege G: A PET study on cortical and subcortical control of pelvic floor musculature in women, J Comp Neurol 389:535n544, 1997. Blok B, van Kerrebroeck P, de Wachter S, et al: Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder, Neurourol Urodyn 37(S2):S9nS16, 2018. Blok B, van Kerrebroeck P, de Wachter S, et al: Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder, Neurourol Urodyn 37:S17nS22, 2018. Blok BF, van Maarseveen JT, Holstege G: Electrical stimulation of the sacral dorsal gray commissure evokes relaxation of the external urethral sphincter in the cat, Neurosci Lett 249:68n70, 1998. Blok BF, Willemsen AT, Holstege G: A PET study on brain control of micturition in humans, Brain 120:11n21, 1997. Boger A, Bhadra N, Gustafson KJ: Bladder voiding by combined high frequency electrical pudendal nerve block and sacral root stimulation, Neurourol Urodyn 27:435n439, 2008.
• Yokogi, H., Wada, Y., Mitztani, M. et al. Bacillus Calmette- Guerin perfusion therapy for carcinoma in situ of the upper urinary tract. Br J Urol 1996;77:676-679.
• KOLLEF M:Appropriate empirical antibacterial therapy for nosocomial infections: Getting it right the first time.Drugs 63:2157, 2003.
• Miskry T, Magos A. Hysterectomy. In: Cardozo L, Staskin D, eds. Textbook of Female Urology and Urogynaecology London: Isis Medical Media; 2001:675-689.